280 related articles for article (PubMed ID: 24474780)
1. Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis.
Mangione PP; Porcari R; Gillmore JD; Pucci P; Monti M; Porcari M; Giorgetti S; Marchese L; Raimondi S; Serpell LC; Chen W; Relini A; Marcoux J; Clatworthy IR; Taylor GW; Tennent GA; Robinson CV; Hawkins PN; Stoppini M; Wood SP; Pepys MB; Bellotti V
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1539-44. PubMed ID: 24474780
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.
McCutchen SL; Lai Z; Miroy GJ; Kelly JW; Colón W
Biochemistry; 1995 Oct; 34(41):13527-36. PubMed ID: 7577941
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway.
Dasari AKR; Arreola J; Michael B; Griffin RG; Kelly JW; Lim KH
Biochemistry; 2020 Jun; 59(25):2319-2327. PubMed ID: 32500705
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activation triggers transthyretin amyloidogenesis
Mangione PP; Verona G; Corazza A; Marcoux J; Canetti D; Giorgetti S; Raimondi S; Stoppini M; Esposito M; Relini A; Canale C; Valli M; Marchese L; Faravelli G; Obici L; Hawkins PN; Taylor GW; Gillmore JD; Pepys MB; Bellotti V
J Biol Chem; 2018 Sep; 293(37):14192-14199. PubMed ID: 30018138
[TBL] [Abstract][Full Text] [Related]
5. Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease.
Klimtchuk ES; Prokaeva T; Frame NM; Abdullahi HA; Spencer B; Dasari S; Cui H; Berk JL; Kurtin PJ; Connors LH; Gursky O
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6428-E6436. PubMed ID: 29941560
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
[TBL] [Abstract][Full Text] [Related]
7. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
[TBL] [Abstract][Full Text] [Related]
8. The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.
Sant'Anna R; Braga C; Varejão N; Pimenta KM; Graña-Montes R; Alves A; Cortines J; Cordeiro Y; Ventura S; Foguel D
J Biol Chem; 2014 Oct; 289(41):28324-37. PubMed ID: 25086037
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel.
Verona G; Mangione PP; Raimondi S; Giorgetti S; Faravelli G; Porcari R; Corazza A; Gillmore JD; Hawkins PN; Pepys MB; Taylor GW; Bellotti V
Sci Rep; 2017 Mar; 7(1):182. PubMed ID: 28298647
[TBL] [Abstract][Full Text] [Related]
10. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.
Rodrigues JR; Simões CJ; Silva CG; Brito RM
Protein Sci; 2010 Feb; 19(2):202-19. PubMed ID: 19937650
[TBL] [Abstract][Full Text] [Related]
11. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
Ueda M; Okada M; Mizuguchi M; Kluve-Beckerman B; Kanenawa K; Isoguchi A; Misumi Y; Tasaki M; Ueda A; Kanai A; Sasaki R; Masuda T; Inoue Y; Nomura T; Shinriki S; Shuto T; Kai H; Yamashita T; Matsui H; Benson MD; Ando Y
J Biol Chem; 2019 Jul; 294(29):11259-11275. PubMed ID: 31167790
[TBL] [Abstract][Full Text] [Related]
12. Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?
Palaninathan SK
Curr Med Chem; 2012; 19(15):2324-42. PubMed ID: 22471981
[TBL] [Abstract][Full Text] [Related]
13. Uncovering the Mechanism of Aggregation of Human Transthyretin.
Saelices L; Johnson LM; Liang WY; Sawaya MR; Cascio D; Ruchala P; Whitelegge J; Jiang L; Riek R; Eisenberg DS
J Biol Chem; 2015 Nov; 290(48):28932-43. PubMed ID: 26459562
[TBL] [Abstract][Full Text] [Related]
14. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.
Lashuel HA; Wurth C; Woo L; Kelly JW
Biochemistry; 1999 Oct; 38(41):13560-73. PubMed ID: 10521263
[TBL] [Abstract][Full Text] [Related]
15. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).
Saraiva MJ; Birken S; Costa PP; Goodman DS
J Clin Invest; 1984 Jul; 74(1):104-19. PubMed ID: 6736244
[TBL] [Abstract][Full Text] [Related]
16. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
Lim A; Prokaeva T; McComb ME; Connors LH; Skinner M; Costello CE
Protein Sci; 2003 Aug; 12(8):1775-85. PubMed ID: 12876326
[TBL] [Abstract][Full Text] [Related]
17. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils.
Redondo C; Damas AM; Olofsson A; Lundgren E; Saraiva MJ
J Mol Biol; 2000 Dec; 304(3):461-70. PubMed ID: 11090287
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
[TBL] [Abstract][Full Text] [Related]
19. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.
Miyata M; Sato T; Mizuguchi M; Nakamura T; Ikemizu S; Nabeshima Y; Susuki S; Suwa Y; Morioka H; Ando Y; Suico MA; Shuto T; Koga T; Yamagata Y; Kai H
Biochemistry; 2010 Jan; 49(1):114-23. PubMed ID: 19950966
[TBL] [Abstract][Full Text] [Related]
20. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
